UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$850M |
| 2 |
Apple
AAPL
|
+$778M |
| 3 |
Tesla
TSLA
|
+$569M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$351M |
| 5 |
Johnson & Johnson
JNJ
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Meta Platforms (Facebook)
META
|
+$237M |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$223M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$217M |
| 5 |
Vertiv
VRT
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.83% |
| 2 | Healthcare | 7.49% |
| 3 | Financials | 7.15% |
| 4 | Consumer Discretionary | 4.92% |
| 5 | Industrials | 4.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
Uranium Energy
UEC
$5.73B
| $1.25M | ﹤0.01% |
321,246
-91,958
| -22% | -$349K |
|
|
SFIX
3852
Stitch Fix
SFIX
$487M
| $1.25M | ﹤0.01% |
400,409
+124,246
| +45% | +$465K |
|
|
AXNX
3853
DELISTED
Axonics, Inc. Common Stock
AXNX
| $1.24M | ﹤0.01% |
19,871
+6,807
| +52% | +$452K |
|
|
SBR
3854
Sabine Royalty Trust
SBR
$1.06B
| $1.24M | ﹤0.01% |
14,522
-3,983
| -22% | -$329K |
|
3855
Onto Innovation
ONTO
$20.7B
| $1.24M | ﹤0.01% |
18,220
+12,471
| +217% | +$896K |
|
3856
CALL
Teck Resources
TECK
$33.1B
| $1.24M | ﹤0.01% |
32,800
-30,100
| -48% | -$1.04M |
|
3857
Seres Therapeutics
MCRB
$47.2M
| $1.24M | ﹤0.01% |
11,062
+9,273
| +518% | +$1.24M |
|
3858
John Hancock Multifactor Developed International ETF
JHMD
$990M
| $1.24M | ﹤0.01% |
43,962
+33,107
| +305% | +$891K |
|
3859
WisdomTree International MidCap Dividend Fund
DIM
$168M
| $1.24M | ﹤0.01% |
22,301
-42,192
| -65% | -$2.22M |
|
3860
Gerdau
GGB
$9.42B
| $1.24M | ﹤0.01% |
281,287
+181,034
| +181% | +$779K |
|
3861
Frontier Group Holdings
ULCC
$1.57B
| $1.24M | ﹤0.01% |
120,408
-15,149
| -11% | -$176K |
|
3862
Byline Bancorp
BY
$1.78B
| $1.24M | ﹤0.01% |
53,800
-6,011
| -10% | -$135K |
|
3863
Arcus Biosciences
RCUS
$3.68B
| $1.24M | ﹤0.01% |
59,748
+20,052
| +51% | +$552K |
|
3864
Gates Industrial Corporation Ltd.
GTES
$7.13B
| $1.23M | ﹤0.01% |
108,135
+42,607
| +65% | +$470K |
|
3865
Travel + Leisure Co
TNL
$4.53B
| $1.23M | ﹤0.01% |
33,887
-134
| -0.4% | -$5.02K |
|
3866
CALL
Unity
U
$19B
| $1.23M | ﹤0.01% |
+43,052
| New | +$1.35M |
|
|
FLNA
3867
Filana Therapeutics
FLNA
$46.1M
| $1.23M | ﹤0.01% |
41,648
+11,001
| +36% | +$395K |
|
|
SJR
3868
DELISTED
Shaw Communications Inc.
SJR
| $1.23M | ﹤0.01% |
42,739
-1,859
| -4% | -$48.8K |
|
|
OLPX
3869
DELISTED
Olaplex Holdings
OLPX
| $1.23M | ﹤0.01% |
236,023
+16,489
| +8% | +$97.9K |
|
3870
Criteo S.A. Ordinary Shares
CRTO
$858M
| $1.23M | ﹤0.01% |
47,176
+1,202
| +3% | +$31.1K |
|
3871
Dine Brands
DIN
$453M
| $1.23M | ﹤0.01% |
19,020
+1,930
| +11% | +$134K |
|
|
ACCD
3872
PUT
DELISTED
Accolade Inc
ACCD
| $1.23M | ﹤0.01% |
157,600
+110,100
| +232% | +$1.05M |
|
|
BRY
3873
DELISTED
Berry Corp
BRY
| $1.22M | ﹤0.01% |
152,918
-11,215
| -7% | -$96K |
|
3874
CALL
RLX Technology
RLX
$2.47B
| $1.22M | ﹤0.01% |
+531,500
| New | +$943K |
|
3875
Caribou Biosciences
CRBU
$167M
| $1.22M | ﹤0.01% |
194,651
+145,749
| +298% | +$1.3M |
|
Similar funds
UBS Group's Q4 2022 Portfolio in Review
As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,214 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.
- UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
- UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
- UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
- UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
- UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
- UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
- UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.
Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.